CLINICAL_TRIALS
trial_result
· 2019-02-01
Clinical Trial Update: Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Intravenously to Healthy Adult Volunteers [Phase 1]
Summary
Phase 1 pharmacokinetics study of intravenous ferric pyrophosphate citrate (Triferic) in healthy adult volunteers related to End Stage Renal Disease.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Rockwell Medical Technologies, Inc. | Conditions: End Stage Renal Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-02-01